![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 43, 44931-44937, October 22, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

From the Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, University of Texas at Houston Medical School, Houston, Texas 70030
To attenuate injury during cholestasis, adaptive changes in bile acid transporter expression in the liver provide alternative bile acid excretory pathways. Apical sodium-dependent bile acid transporter (ASBT) (SLC10A2), only expressed in the liver on the cholangiocyte apical membrane, is rapidly regulated in response to inflammation and bile acids. Here, we studied the mechanisms controlling ASBT protein levels in cholangiocytes to determine whether ASBT expression is regulated by ubiquitination and disposal through the proteasome. Protein turnover assays demonstrated that ASBT is an unstable and short-lived protein. Treatment with MG-132, a proteasome inhibitor, causes time-dependent increased ASBT levels and increased intracellular accumulation of ASBT. In cells cotransfected with green fluorescent protein-tagged ASBT and hemagglutinin-tagged ubiquitin, we demonstrated coimmunoprecipitation and colocalization of ASBT and ubiquitin. Interleukin-1
(IL-1
) induced down-regulation of ASBT is abrogated by a JNK inhibitor and is accompanied by an increase in ASBT polyubiquitin conjugates and a reduced ASBT half-life. In phosphorylation-deficient S335A and T339A mutants, the ASBT half-life is markedly prolonged, IL-1
-induced ASBT ubiquitination is significantly reduced, and IL-1
fails to increase ASBT turnover. These results indicate that ASBT undergoes ubiquitin-proteasome degradation under basal conditions and that ASBT proteasome disposal is increased by IL-1
due to JNK-regulated serine/threonine phosphorylation of ASBT protein at both Ser-335 and Thr-339. These studies are the first report of regulation of a bile acid transporter expression by the ubiquitin-proteasome pathway.
Received for publication, January 28, 2004 , and in revised form, August 9, 2004.
* This work was supported by Grant NIDDK RO1 DK 54208 from the NIDDK National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Division of Gastroenterology, Hepatology and Nutrition, Dept. of Internal Medicine, University of Texas at Houston Medical School, 6431 Fannin, MSB 4.234, Houston, TX 770030. Tel.: 713-500-6677; Fax: 713-500-6699; E-mail: Gene.LeSage{at}uth.tmc.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. Smith, X. Su, R. El-Maghrabi, P. D. Stahl, and N. A. Abumrad Opposite Regulation of CD36 Ubiquitination by Fatty Acids and Insulin: EFFECTS ON FATTY ACID UPTAKE J. Biol. Chem., May 16, 2008; 283(20): 13578 - 13585. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Miranda and A. Sorkin Regulation of Receptors and Transporters by Ubiquitination: New Insights into Surprisingly Similar Mechanisms Mol. Interv., June 1, 2007; 7(3): 157 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hatanaka, Y. Hatanaka, and M. Setou Regulation of Amino Acid Transporter ATA2 by Ubiquitin Ligase Nedd4-2 J. Biol. Chem., November 24, 2006; 281(47): 35922 - 35930. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-Q. Sun, N. Balasubramaniyan, H. Chen, M. Shahid, and F. J. Suchy Identification of Functionally Relevant Residues of the Rat Ileal Apical Sodium-dependent Bile Acid Cotransporter J. Biol. Chem., June 16, 2006; 281(24): 16410 - 16418. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |